The Patency Rate of Endovascular Procedure in Patients with Superior Vena Cava Syndrome Caused by Intravenous Catheterization: A Case Series and Longitudinal Study

  • Morteza Noaparast Department of Vascular Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  • Jayran Zebardast Cognitive Science Special Linguistics, Institute of Cognitive Sciences, Tehran, Iran
  • Alireza Namvari Mail Department of General Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Keywords:
Catheterization, Central Venous, Endovascular Procedures, Superior Vena Cava Syndrome

Abstract

Introduction: Different methods have been well addressed in literature in terms of treating superior vena cava (SVC) syndrome; nevertheless, the patency of endovascular treatment has rarely been investigated in patients with SVC syndrome in patients with central venous access. Objectives: The present study was performed to assess the patency rate of endovascular procedure in patients with SVC syndrome caused by intravenous catheterization. Methods: The present case series and longitudinal study was conducted on patients with SVC syndrome in presence of central venous catheter who underwent venoplasty. Computed tomography (CT) venography was performed 1, 6 and 12 months after venoplasty. Facial swelling, facial discomfort, extremity edema, arteriovenous fistula (AVF) dysfunction, impairment in dialysis and SVC stenosis were measured at baseline and 1, 6 and 12 months after venoplasty. Results: Out of 20 investigated patients, 11 (55%) were male. Significantly decreases were observed in the median grades of facial swelling and extremity edema in the follow-up (P<0.001). The decrease in facial discomfort was statistically insignificant (P=0.129), and the median grade of SVC stenosis significantly decreased from 1.5 to zero in the follow-up (P<0.001). A statistically-significant decrease was observed in AVF dysfunction (P=0.007), and impairment in dialysis significantly decreased after the intervention during the follow-up (P<0.001). Conclusion: Findings of the present study revealed the appropriate patency rate of endovascular treatment in patients with SVC syndrome in presence of central venous catheter.

Downloads

Download data is not yet available.

References

1. Shatila W, Almanfi A, Massumi M, Dougherty KG, Parekh DR, Strickman NE. Endovascular treatment of superior vena cava syndrome via balloon-in-balloon catheter technique with a palmaz stent. Tex Heart Inst J. 2016;43(6):520-3.
2. Hinton J, Cerra-Franco A, Shiue K, Shea L, Aaron V, Billows G, et al. Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report. J Med Case Rep. 2018;12:301.
3. Wehbe MR, Hoballah JJ. Superior Vena Cava Syndrome. InCurrent Management of Venous Diseases 2018 (pp. 547-556). Springer, Cham.
4. Kim DH, Jeon YS, Kim GC, Ahn IS, Kwan J, Park KS, et al. Superior vena cava syndrome caused by encircling soft tissue. Korean J Intern Med. 2007;22(2):118-21.
5. Ji D, Gill AE, Ermentrout RM, Hawkins CM. Thrombogenic superior vena cava syndrome from long-standing central venous access in a 5-year-old patient treated with balloon-expandable stents. J Radiol Case Rep. 2018;12(4):15-22.
6. Kalra M, Gloviczki P, Andrews JC, Cherry Jr KJ, Bower TC, Panneton JM, et al. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg. 2003;38(2):215-23.
7. De Raet JM, Vos JA, Morshuis WJ, van Boven WJ. Surgical management of superior vena cava syndrome after failed endovascular stenting. Interact Cardiovasc Thorac Surg. 2012; 15(5):915-7.
8. Brodovicz KG, McNaughton K, Uemura N, Meininger G, Girman CJ, Yale SH. Reliability and feasibility of methods to quantitatively assess peripheral edema. Clin Med Res. 2009;7(1-2):21-31.
9. Kim YI, Kim KS, Ko YC, Park CM, Lim SC, Kim YC, et al. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome. J Korean Med Sci. 2004;19(4):519-22.
10. Zimmerman S, Davis M. Rapid fire: superior vena cava syndrome. Emerg Med Clin North Am. 2018;36(3):577-84.
11. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore). 2006;85(1):37-42.
12. Urruticoechea A, Mesıa R, Domınguez J, Falo C, Escalante E, Montes A, et al. Treatment of malignant superior vena cava syndrome by endovascular stent insertion: experience on 52 patients with lung cancer. Lung Cancer. 2004;43(2):209-14.
13. Kee ST, Kinoshita L, Razavi MK, Nyman UR, Semba CP, Dake MD. Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology. 1998;206(1):187-93.
14. Lanciego C, Chacon JL, Julian A, Andrade J, Lopez L, Martinez B, et al. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR Am J Roentgenol. 2001;177(3):585-93.
15. Kalra M, Gloviczki P, Andrews JC, Cherry Jr KJ, Bower TC, Panneton JM, et al. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg. 2003;38(2):215-23.
16. Dinkel HP, Mettke B, Schmid F, Baumgartner I, Triller J, Do DD. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement? J Endovasc Ther. 2003;10(4):788-97.
17. Bierdrager E, Lampmann LE, Lohle PN, Schoemaker CM, Schijen JH, Palmen FM, et al. Endovascular stenting in neoplastic superior vena cava syndrome prior to chemotherapy or radiotherapy. Neth J Med. 2005;63(1):20-3.
18. Hooker JB, Hawkins BM, Abu-Fadel MS. Endovascular Stenting in 2 Patients with Benign Superior Vena Cava Syndrome. Tex Heart Inst J. 2018;45(4):264-9.
19. Shatila W, Almanfi A, Massumi M, Dougherty KG, Parekh DR, Strickman NE. Endovascular treatment of superior vena cava syndrome via balloon-in-balloon catheter technique with a palmaz stent. Tex Heart Inst J. 2016;43(6):520-3.
20. Nicholson AA, Ettles DF, Arnold A, Greenstone M, Dyet JF. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol. 1997;8(5):781-8.
21. Oderich GS, Treiman GS, Schneider P, Bhirangi K. Stent placement for treatment of central and peripheral venous obstruction: a long-term multi-institutional experience. J Vasc Surg. 2000;32(4):760-9.
22. Brodovicz KG, McNaughton K, Uemura N, Meininger G, Girman CJ, Yale SH.Reliability and feasibility of methods to quantitatively assess peripheral edema. Clin Med Res. 2009;7(1-2):21-31
23. Haefeli M, Elfering A. Pain assessment. Eur Spine J. 2006;15(1):S17-24.
24. Zamboli P, Fiorini F, D’Amelio A, Fatuzzo P, Granata A. Color Doppler ultrasound and arteriovenous fistulas for hemodialysis. J Ultrasound. 2014;17(4):253-63.
Published
2019-12-17
How to Cite
1.
Noaparast M, Zebardast J, Namvari A. The Patency Rate of Endovascular Procedure in Patients with Superior Vena Cava Syndrome Caused by Intravenous Catheterization: A Case Series and Longitudinal Study. Adv J Emerg Med. 4(3):e72.
Section
Original article